These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Simultaneously evoked primary and cognitive visual evoked potentials distinguish younger and older patients with Parkinson's disease. Antal A; Pfeiffer R; Bodis-Wollner I J Neural Transm (Vienna); 1996; 103(8-9):1053-67. PubMed ID: 9013393 [TBL] [Abstract][Full Text] [Related]
9. Electrophysiological Evidence of Auditory and Cognitive Processing Deficits in Parkinson Disease. Folmer RL; Vachhani JJ; Riggins A Biomed Res Int; 2021; 2021():6610908. PubMed ID: 34239927 [TBL] [Abstract][Full Text] [Related]
10. Contribution of auditory P300 test to the diagnosis of mild cognitive impairment in Parkinson's disease. Yilmaz FT; Özkaynak SS; Barçin E Neurol Sci; 2017 Dec; 38(12):2103-2109. PubMed ID: 28887694 [TBL] [Abstract][Full Text] [Related]
11. Relationship between event-related potentials and frontal-subcortical dysfunction in Parkinson's disease. Chen KJ; Lin RT; Liu CK; Tai CT; Lai CL Parkinsonism Relat Disord; 2006 Oct; 12(7):453-8. PubMed ID: 16793318 [TBL] [Abstract][Full Text] [Related]
13. Mild cognitive impairment in Parkinson's disease is associated with decreased P300 amplitude and reduced putamen volume. Hünerli D; Emek-Savaş DD; Çavuşoğlu B; Dönmez Çolakoğlu B; Ada E; Yener GG Clin Neurophysiol; 2019 Aug; 130(8):1208-1217. PubMed ID: 31163365 [TBL] [Abstract][Full Text] [Related]
14. CERAD test performance and cognitive impairment in Parkinson's disease. Karrasch M; Laatu S; Martikainen K; Marttila R Acta Neurol Scand; 2013 Dec; 128(6):409-13. PubMed ID: 23668316 [TBL] [Abstract][Full Text] [Related]
15. The influence of motor and cognitive impairment upon visually-guided saccades in Parkinson's disease. Macaskill MR; Graham CF; Pitcher TL; Myall DJ; Livingston L; van Stockum S; Dalrymple-Alford JC; Anderson TJ Neuropsychologia; 2012 Dec; 50(14):3338-47. PubMed ID: 23000134 [TBL] [Abstract][Full Text] [Related]
16. Modality dependent changes in event-related potentials correlate with specific cognitive functions in nondemented patients with Parkinson's disease. Bodis-Wollner I; Borod JC; Cicero B; Haywood CS; Raskin S; Mylin L; Sliwinski M; Falk A; Yahr MD J Neural Transm Park Dis Dement Sect; 1995; 9(2-3):197-209. PubMed ID: 8527004 [TBL] [Abstract][Full Text] [Related]
17. [P300 clinical utility in major depression]. Ortiz Alonso T; Pérez-Serrano JM; Zaglul Zaiter C; Coullaut García J; Coullaut García R; Criado Rodríguez J Actas Esp Psiquiatr; 2002; 30(1):1-6. PubMed ID: 11893284 [TBL] [Abstract][Full Text] [Related]
18. Visuo-cognitive dysfunctions in Parkinson's disease. Antal A; Bandini F; Kéri S; Bodis-Wollner I Clin Neurosci; 1998; 5(2):147-52. PubMed ID: 10785841 [TBL] [Abstract][Full Text] [Related]
19. [Neurophysiological study and use of P300 evoked potentials for investigation in the diagnosis and of follow-up of patients with Alzheimer s disease]. Fernández- Lastra A; Morales-Rodríguez M; Penzol-Díaz J Rev Neurol; 2001 Mar 16-31; 32(6):525-8. PubMed ID: 11353989 [TBL] [Abstract][Full Text] [Related]
20. Auditory event-related potentials in Parkinson's disease: prominent correlation with attention. Matsui H; Nishinaka K; Oda M; Kubori T; Udaka F Parkinsonism Relat Disord; 2007 Oct; 13(7):394-8. PubMed ID: 17329143 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]